Insights from 2023 ASCO® Annual Meeting

 

GYN
08:10

Insights from 2023 ASCO® Annual Meeting

Initial Efficacy & Safety Results From a Phase 2 ENGOT-ov60/GOG-3052/RAMP 201 Study: Avutometinib (VS-6766) ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

FEATURING Susana Banerjee
  • 110 views
  • October 11, 2023
12:42

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "RUBY Trial - PROs in Primary Advanced or Recurrent Endometrial Cancer for Pts Treated With Dostarlimab + Carboplatin/Paclitaxel vs. CP"

FEATURING Mansoor Raza Mirza
  • 194 views
  • June 23, 2023
  • 1
07:24

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "BRCA1 and RAD51 Methylation Impact on Outcome in Pts With Advanced Ovarian Cancer - A PAOLA-1 Ancillary Study"

FEATURING Helene Blons
  • 140 views
  • June 15, 2023
06:29

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "TEDOVA Trial - Neo-Epitope Based Vaccine Alone or in Combination With Pembro vs. BSC as Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer With Disease Control After Platinum"

FEATURING Alexandra Leary
  • 380 views
  • June 9, 2023
09:28

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609 - The Vulvar Cancers"

FEATURING Young Chae
  • 160 views
  • June 8, 2023